Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities
Net loss	$ (107,589)	$ (50,027)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of property and equipment	186	276
Amortization of platform development and intangible assets	9,550	20,834
Amortization of debt discounts	626	2,178
Noncash and accrued interest	8,423	754
Loss on impairment of assets	40,589	119
Change in fair value of contingent consideration	313	469
Liquidated damages	229	455
Stock-based compensation	2,736	16,978
Deferred income taxes	93	109
Bad debt expense	1,269	217
Other	(19)
Change in operating assets and liabilities net of effect of business combination:
Accounts receivable, net	17,051	(4,213)
Subscription acquisition costs	6,131	(1,631)
Prepayments and other current assets	923	(2,465)
Other long-term assets	647	(62)
Accounts payable	(4,171)	(1,719)
Accrued expenses and other	35,069	1,670
Unearned revenue	(17,145)	(146)
Subscription refund liability	70	(95)
Operating lease liabilities	(445)	(171)
Contingent consideration	(1,683)
Other long-term liabilities	(360)	(5,795)
Net cash used in operating activities	(7,507)	(22,265)
Cash flows from investing activities
Purchases of property and equipment	(54)
Capitalized platform development	(2,765)	(2,967)
Payments for acquisition of business, net of cash acquired		(500)
Net cash used in investing activities	(2,819)	(3,467)
Cash flows from financing activities
Proceeds from bridge notes		5,703
Payment of Fexy put option	(561)
(Repayments) proceeds under line of credit, net borrowing	(20,027)	3,211
Proceeds from common stock private placement	12,000
Proceeds from Simplify loan	16,100
Proceeds from common stock registered direct offering		11,500
Payments of issuance costs from common stock registered direct offering		(167)
Payments of debt issuance costs		(100)
Payment of deferred cash payments	(200)	(75)
Payment of taxes from common stock withheld	(497)	(1,423)
Net cash provided by financing activities	6,815	18,649
Net decrease in cash and cash equivalents	(3,511)	(7,083)
Cash and cash equivalents – beginning of year	9,284	14,373
Cash and cash equivalents – end of period	5,773	7,290
Supplemental disclosure of cash flow information
Cash paid for interest	2,698	10,835
Cash paid for income taxes	85	85
Noncash investing and financing activities
Reclassification of stock-based compensation to platform development	245	785
Issuance cost of registered direct offering recorded in accrued expenses and other		189
Repurchase of common stock for Fexy put option	379
Issuance of common stock pursuant to common stock purchase agreement in connection with exchange of debt	15,000
Issuance of common stock in connection with settlement of liquidated damages		499
Issuance of common stock upon conversion of Series H convertible preferred stock		13,008
Issuance of common stock in connection with acquisition		2,000
Deferred cash payments recorded in connection with acquisitions		246
Assumptions of liabilities in connection with acquisitions		1,246
Reclassification to liability upon common stock modification		$ 68